Paragon 28 Secures $12 million in Funding to Elevate Foot and Ankle Surgery Innovations

In a significant milestone for growth and innovation, Paragon 28, an esteemed orthopedic foot and ankle company, has successfully raised $12 million in funding.

Established in 2010, Paragon 28 was built on the purpose-driven mission to transform the landscape of foot and ankle surgery.

The company’s name reflects its unwavering commitment to this niche of orthopedics, with "28" symbolizing the total number of bones in the foot.

This latest infusion of capital will be instrumental in advancing their core principles: fostering creativity through enhanced surgical solutions, maintaining exceptional customer service, and developing practical and comprehensive systems tailored for foot and ankle surgeons.

Paragon 28 aims to blend diverse surgical philosophies from global thought leaders to innovate wholly new approaches while remaining responsive to the increasing pressures of pricing and reimbursement in healthcare.

Additionally, the company is keen on leveraging the funding to enhance research initiatives that improve clinical outcomes, emphasizing a commitment to integrity and unbiased results.

The Paragon 28 team is fueled by a dynamic culture that prizes motivation, competition, and continuous learning, and they are currently seeking to expand their workforce across various departments, including Quality, Engineering, and Marketing.

As Paragon 28 embarks on this exciting new chapter, the company’s vision remains focused: to enhance the quality of life for patients through groundbreaking advancements in foot and ankle care.